Advanced search
Publication Cover
Acta Cardiologica Volume 65, 2010 - Issue 6
Submit an article Journal homepage
3
Views
10
CrossRef citations to date
0
Altmetric
Articles

Metabolic syndrome does not impose greater atrial fibrillation risk in elderly hypertensive patients

Yu-Feng HuDivision of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.;Institute of Clinical Medicine, and Cardiovascular Research Institute, National Yang-Ming University, Taipei, Taiwan.
, MD,
Shih-Ann ChenDivision of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.;Institute of Clinical Medicine, and Cardiovascular Research Institute, National Yang-Ming University, Taipei, Taiwan.
, MD &
Hung-I YehDepartment of Internal Medicine, Mackay Memorial Hospital, Mackay Medical College, Taipei, Taiwan.;Graduate Institute of Medical Science, Taipei Medical University, Taipei, Taiwan.Correspondence[email protected]
, MD, PhD
Pages 653-659 | Received 30 Jul 2010, Accepted 26 Aug 2010, Published online: 23 May 2017

References

  • Echahidi N, Mohty D, Pibarot P. Després JP, O'Hara G, Champagne J, Philippon F, Daleau P, Voisine P. Mathieu P. Obesity and metabolic syndrome are independent risk fac-tors for atrial fibrillation after coronary artery bypass graft surgery. Circulation 2007; 116: 1213–9.
  • Watanabe H, Tanabe N, Watanabe T, Darbar D, Roden DM, Sasaki S, Aizawa Y Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation 2008; 117: 1255–60.
  • Wachtell K, Lehto M, Gerdts E, Olsen MH, Homestam B, Dahlöf B, Ibsen H, Julius S, Kjeldsen SE, Lindholm LH, Nieminen MS, Devereux RB. Angiotensin II receptor block-ade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol 2005; 45: 712–9.
  • Hung TC, Chen CY, Cheng SJ, Liu CH, Yeh HI. Compari-son of the prevalence of metabolic syndrome between the criteria for Taiwanese and Japanese and the projected prob-ability of stroke in elderly hypertensive Taiwanese. Int J Gerontol 2009; 3: 233–40.
  • Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998; 82: 2–9.
  • Schnabel RB, Sullivan LM, Levy D, Pencina MJ, Massaro JM, D'Agostino RB Sr, Newton-Cheh C, Yamamoto JF, Magnani JVV, Tadros TM, Kannel WB, Wang TJ, Ellinor PT, Wolf PA, Vasan RS, Benjamin EJ. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet 2009; 373: 739–45.
  • Vagaonescu TD, Wilson AC, Kostis JB. Atrial fibrillation and isolated systolic hypertension: the systolic hypertension in the elderly program and systolic hypertension in the elderly program-extension study. Hypertension 2008; 51: 1552–6.
  • Vermes E, Tardif JC, Bourassa MG, Racine N, Levesque S, White M, Guerra PG, Ducharme A. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricu-lar dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials. Circulation 2003; 107: 2926–31.
  • Gottdiener JS, Reda DJ, Williams DW, Materson BJ, Cush-man W, Anderson RJ. Effect of single-drug therapy on reduction of left atrial size in mild to moderate hyperten-sion: comparison of 6 antihypertensive agents. Circulation 1998; 98: 140–8.
  • Adam O, Neuberger HR, Böhm M, Laufs U. Prevention of atrial fibrillation with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Circulation 2008; 118: 1285–93.
  • Young-Xu Y, Jabbour S, Goldberg R, Blatt CM, Graboys T, Bilchik B, Ravid S. Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. Am J Cardiol 2003; 92: 1379–83.
  • Patti G, Chello M, Candura D, Pasceri V, D'Ambrosio A, Covino E, Di Sciascio G. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation 2006; 114: 1455–61.
  • Marin F, Pascual DA, Roldan V, Arribas JM, Ahumada M, Tomei PL, Oliver C, Gomez-Plana J, Lip GY, Valdes M. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Am J Cardiol 2006; 97: 55–60.
  • Amar D, Zhang H, Heerdt PM, Park B, Fleisher M, Thaler HT. Statin use is associated with a reduction in atrial fibril-lation after noncardiac thoracic surgery independent of C-reactive protein. Chest 2005; 128: 3421–7.
  • Almroth H, Höglund N, Boman K, Englund A, Jensen S, Kjellman B, Tomvall P, Rosenqvist M. Atorvastatin and persistent atrial fibrillation following cardioversion: a rand-omized placebo-controlled multicentre study. Eur Heart J 2009; 30: 827–33.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.